To investigate the role of ATP6V0A1 in anti-tumor immunity in the context of human immune and colon cancer cells, we established a subcutaneous human colon cancer model in immunodeficient mice engrafted with human-derived immune cells (Supplementary Fig. 6B, C). This evidence concerns the gene ATP6V0A1 and malignant colon neoplasm.